Interchangeability of three recombinant anti-HBV vaccines in primary schedule, irrespective of dose and HBsAg subtype: the first prospective, open-label, randomized study in healthy adult population.

Interchangeability of three recombinant anti-HBV vaccines in primary schedule, irrespective of dose and HBsAg subtype: the first prospective, open-label, randomized study in healthy adult population. Pol Arch Med Wewn. 2015 Sep 3; Authors: Rymer W, Zalewska M, Szymczak A, Zubkiewicz-Zarębska A, Knysz B PMID: 26334563 [PubMed - as supplied by publisher]
Source: Polskie Archiwum Medycyny Wewnetrznej - Category: Internal Medicine Tags: Pol Arch Med Wewn Source Type: research